Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Clinical trial NCT02466477 · COMPLETED
Trial details
- NCT number
- NCT02466477
- Sponsor
- Assurex Health Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2018-11-01
- Enrollment
- 542
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.